Ocular surface tear film and epithelial layer

The ocular surface tear film and epithelial layer represent a complex, integrated functional unit essential for maintaining the health and optical quality of the eye. The tear film is a dynamic structure—comprising an outer lipid layer produced by meibomian glands, a middle aqueous layer from lacrimal glands, and an inner mucin layer from goblet cells—that provides lubrication, nutrients, and a smooth refractive interface (StatPearls, Physiology, Tear Film, 2023). The underlying epithelial layer, consisting of the cornea and conjunctiva, serves as a critical physical and immunological barrier against environmental pathogens and desiccation (TFOS DEWS II, 2017). Dysfunction in this system leads to dry eye disease, characterized by a loss of homeostasis, tear hyperosmolarity, and ocular surface inflammation (PubMed, PMID: 28736335). Pharmacological treatments target this system by reducing inflammation (e.g., Cyclosporine), stabilizing the lipid layer (e.g., Perfluorohexyloctane), or stimulating natural tear production via neural pathways (e.g., Varenicline). Maintaining the integrity of this system is vital for preventing corneal scarring and ensuring visual acuity.

Other names

Precorneal tear filmOcular surface unitCorneal-conjunctival epithelium

Drugs targeting this system act through various mechanisms including the inhibition of T-cell mediated inflammation, blocking the interaction between LFA-1 and ICAM-1 to reduce cytokine release, stimulating the trigeminal parasympathetic pathway to increase natural tear production, and providing physical lubrication or evaporation barriers to stabilize the tear film.